Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema

Overview

Journal Eur J Breast Health

Publisher Galenos Publishing House

Date 2017 Sep 13

PMID 28894851

Citations 7

Authors

Yesim Bakar

Alper Tugral

Ozlem Ozdemir

Elif Duygu

Ummugul Uyeturk

Affiliations

Soon will be listed here.

Abstract

Objective: Breast cancer related lymphedema (BCRL) is a drastic situation that affects patients who have undergone breast cancer surgery. The impact of this condition on individuals' quality of life should be investigated in more detail to obtain better treatment results.

Materials And Methods: In total, 65 patients with BCRL participated in this study. Nottingham Health Profile (NHP) was used to evaluate the validity of associated domains in Lymphedema Quality of Life Tool (LYMQoL). Both the LYMQoL and NHP were filled out by BCRL patients. To evaluate its test-retest reliability, the LYMQoL was subsequently performed seven days following its initial application. Measurement properties such as internal consistency, test-retest reliability, criterion validity and factor structure were tested. The internal consistency was assessed via Cronbach's alpha; test-retest reliability was assessed by the intra-class correlation coefficient (ICC).

Results: Cronbach's alpha values ranged from 0.74 to 0.91 for the LYMQoL total and domain scores. Test-retest reliability was excellent (ICC=0.92-0.99). When the relation between LYMQoL and NHP was investigated, 'good' to 'very good' correlations were obtained (r=0.539-0.643, p<0.05) for all domains of LYMQoL. Exploratory factor analyses demonstrated a four-factor structure.

Conclusion: Turkish version of LYMQoL is a valid and reliable measurement tool to evaluate the quality of life in patients with BCRL.

Citing Articles

Translation, Cross-Cultural Adaptation and Validation of the Lymphedema Quality of Life Questionnaire (LYMQOL) in German-Speaking Patients with Upper Limb Lymphedema.

Schulz T, Lee Warg M, Heister S, Lidzba K, Ciklatekerlio G, Molter Y Healthcare (Basel). 2024; 12(18).

PMID: 39337222 PMC: 11431024. DOI: 10.3390/healthcare12181881.

Translation, Cross-Cultural Adaptation and Validation of the Lymphedema Quality of Life Questionnaire (LYMQOL) in German-Speaking Patients with Lymphedema of the Lower Limbs.

Nuwayhid R, Lee Warg M, Heister S, Langer S, Schulz T Healthcare (Basel). 2024; 12(3).

PMID: 38338294 PMC: 10855540. DOI: 10.3390/healthcare12030409.

Psychometric performance of the Arabic versions of the Functional Assessment of Cancer Therapy-Breast plus Arm morbidity (FACT-B + 4) in patients with breast cancer related lymphedema: cross-sectional study.

Al-Hoqail H, Omar M, Al-Marwani M, Al-Eisa E BMC Womens Health. 2022; 22(1):207.

PMID: 35658863 PMC: 9166420. DOI: 10.1186/s12905-022-01787-x.

Psychometric Properties of Quality of Life Questionnaires for Patients with Breast Cancer-Related Lymphedema: A Systematic Review.

Meilani E, Zanudin A, Mohd Nordin N Int J Environ Res Public Health. 2022; 19(5).

PMID: 35270209 PMC: 8909332. DOI: 10.3390/ijerph19052519.

Validity and reliability of the Turkish version of the lymphedema symptom intensity and distress survey.

Deveci Z, Karayurt O, Celik B, Eyigor S Turk J Phys Med Rehabil. 2022; 67(4):428-438.

PMID: 35141483 PMC: 8790268. DOI: 10.5606/tftrd.2021.6228.

References

Marx R, Menezes A, Horovitz L, Jones E, Warren R . A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol. 2003; 56(8):730-5. DOI: 10.1016/s0895-4356(03)00084-2. View

Morgan P, Franks P, Moffatt C . Health-related quality of life with lymphoedema: a review of the literature. Int Wound J. 2006; 2(1):47-62. PMC: 7951421. DOI: 10.1111/j.1742-4801.2005.00066.x. View

Kibar S, Dalyan Aras M, Unsal Delialioglu S . The risk factors and prevalence of upper extremity impairments and an analysis of effects of lymphoedema and other impairments on the quality of life of breast cancer patients. Eur J Cancer Care (Engl). 2016; 26(4). DOI: 10.1111/ecc.12433. View

Shi S, Lu Q, Fu M, Ouyang Q, Liu C, Lv J . Psychometric properties of the Breast Cancer and Lymphedema Symptom Experience Index: The Chinese version. Eur J Oncol Nurs. 2015; 20:10-6. DOI: 10.1016/j.ejon.2015.05.002. View

Ridner S, Dietrich M, Kidd N . Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life. Support Care Cancer. 2010; 19(5):631-7. DOI: 10.1007/s00520-010-0870-5. View

Shamliyan T, Kane R, Dickinson S . A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. J Clin Epidemiol. 2010; 63(10):1061-70. DOI: 10.1016/j.jclinepi.2010.04.014. View

DiSipio T, Rye S, Newman B, Hayes S . Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013; 14(6):500-15. DOI: 10.1016/S1470-2045(13)70076-7. View

Viehoff P, van Genderen F, Wittink H . Upper limb lymphedema 27 (ULL27): Dutch translation and validation of an illness-specific health-related quality of life questionnaire for patients with upper limb lymphedema. Lymphology. 2008; 41(3):131-8. View

Mirolo B, Bunce I, Chapman M, Olsen T, Eliadis P, Hennessy J . Psychosocial benefits of postmastectomy lymphedema therapy. Cancer Nurs. 1995; 18(3):197-205. View

10.

Thomas-Maclean R, Miedema B, Tatemichi S . Breast cancer-related lymphedema: women's experiences with an underestimated condition. Can Fam Physician. 2006; 51:246-7. PMC: 1472970. View

11.

Velanovich V, Szymanski W . Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999; 177(3):184-7; discussion 188. DOI: 10.1016/s0002-9610(99)00008-2. View

12.

Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens M . Lymphoedema Functioning, Disability and Health questionnaire (Lymph-ICF): reliability and validity. Phys Ther. 2011; 91(6):944-57. DOI: 10.2522/ptj.20100087. View

13.

Paskett E, Naughton M, McCoy T, Case L, Abbott J . The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2007; 16(4):775-82. PMC: 4771019. DOI: 10.1158/1055-9965.EPI-06-0168. View

14.

Iuchi T, Dai M, Sanada H, Okuwa M, Nakatani T, Sugama J . Associations between the treatments and outcomes of patients with upper and lower lymphoedema in Japan: a cross-sectional observational study. Int J Nurs Stud. 2015; 52(5):913-9. DOI: 10.1016/j.ijnurstu.2015.01.011. View

15.

Ridner S, Bonner C, Deng J, Sinclair V . Voices from the shadows: living with lymphedema. Cancer Nurs. 2011; 35(1):E18-26. PMC: 3172392. DOI: 10.1097/NCC.0b013e31821404c0. View

16.

Beaton D, Bombardier C, Guillemin F, Ferraz M . Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000; 25(24):3186-91. DOI: 10.1097/00007632-200012150-00014. View

17.

Kucukdeveci A, McKenna S, Kutlay S, Gursel Y, Whalley D, Arasil T . The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res. 2000; 23(1):31-8. DOI: 10.1097/00004356-200023010-00004. View

18.

Patel K, Lin C, Cheng M . A Prospective Evaluation of Lymphedema-Specific Quality-of-Life Outcomes Following Vascularized Lymph Node Transfer. Ann Surg Oncol. 2014; 22(7):2424-30. DOI: 10.1245/s10434-014-4276-3. View

19.

van de Pas C, Biemans A, Boonen R, Viehoff P, Neumann H . Validation of the Lymphoedema Quality-of-Life Questionnaire (LYMQOL) in Dutch Patients Diagnosed with Lymphoedema of the Lower Limbs. Phlebology. 2015; 31(4):257-63. DOI: 10.1177/0268355515586312. View

20.

Smoot B, Wong J, Cooper B, Wanek L, Topp K, Byl N . Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv. 2010; 4(2):167-78. PMC: 2882040. DOI: 10.1007/s11764-010-0118-x. View